chrisvoncsefalvay/vaers-outcomes huggingface dataset:
delirium; fell in the night/fallen; extreme fatigue; memory loss/memory problem prior to getting the vaccine, however, now it was worse; memory loss/memory problem prior to getting the vaccine, however, now it was worse; This is a spontaneous report from contactable other healthcare professionals. An 87-year-old female patient received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EN5318), via an unspecified route of administration in the left arm on 01Feb2021 14:00 at a single dose for covid-19 immunization. Medical history included blood pressure abnormal, glaucoma, thyroid problems, mild cognitive impairment and memory problem. Concomitant medication included amlodipine, atorvastatin and carvedilol for blood pressure, donepezil for mild cognitive impairment, ezetimibe, levothyroxine for thyroid problems and ongoing latanoprost for glaucoma. The patient previously received first dose of bnt162b2 (lot number: EL3246) on 11Jan2021 for covid-19 immunization. On an unspecified date in Feb2021, the patient had fallen, did not hit her head, but she has extreme fatigue, memory loss (she has seen some improvement now) unable to be by herself now and take her medications. The patient had a mild case of memory loss and had delirium. The reporter cannot say these events occurred from the vaccine of course. However, the work up that has been done has been negative and reporter was worried. It was reported that the patient had a little memory problem prior to getting the vaccine, however, now it was worse. It was like the patient cannot be alone now. The patient did not have a stroke. However, this like sent the patient over a cliff. This is a life changing event. If patient gets better it's all good, but if she does not they are in big trouble. Patient was previously able to care for self and now she was not able too. Patient underwent lab test (unknown result) in Feb2021. Patient was taken to Urgent Care, was seen by a physician and basic blood work was done and a urine test was done (unknown result). The outcome of event delirium was recovering; all other events was unknown.   Information on Lot/Batch has been requested.
shot at2pm by 5:15pm rt shoulder started hurting  continued to get worse could not lift arm out raise up          nostrength inshoulder upper arm  severe pain  could not continue to work  could not turn a light switch on  pull open a fridge door  screaming when trying to pullup my pants, screaming   toget bra off &on shirt on by mon am could  get dressed minimum pain armlesspain still no strength  still can not reach out or up
Developed sensation over dermatome of abdomen within 1 hr of 1st dose of Pfizer vaccine.  Increased pain over 3 days.  Eruption of herpes zoster rash on 3/22 with confirmation by provider on 3/23.
Patient missed her 2nd dose, more than 42 days; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Jun-2021 and was forwarded to Moderna on 17-Jun-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of INTENTIONAL DOSE OMISSION (Patient missed her 2nd dose, more than 42 days) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Crohn's disease. Concomitant products included DILTIAZEM (CARDIZEM [DILTIAZEM]), PROBIOTICS NOS, VITAMIN B COMPLEX, TOCOPHEROL (VITAMIN E NATURAL [TOCOPHEROL]) and ADALIMUMAB (HUMIRA) for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (Patient missed her 2nd dose, more than 42 days). At the time of the report, INTENTIONAL DOSE OMISSION (Patient missed her 2nd dose, more than 42 days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.
Client reports "vaccines on 11/21/01 at 10:30 AM" followed by "slight headache, sore arm and felt tired". On 11/22/01, client reports she awoke at 02:30 with "choking, very sore and swollen throat and positional apnea". Client states she "took an antihistamine" and "improved in 1 1/2 hours".
more than 36 days have passed since the first dose and the patient has not received the second dose; felt as if she was pumped on coffee; Uncomfortable neck/neck felt like it was very tense, there was some tension there; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt as if she was pumped on coffee), FEELING ABNORMAL (Uncomfortable neck/neck felt like it was very tense, there was some tension there) and PRODUCT DOSE OMISSION ISSUE (more than 36 days have passed since the first dose and the patient has not received the second dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced FEELING ABNORMAL (felt as if she was pumped on coffee) and FEELING ABNORMAL (Uncomfortable neck/neck felt like it was very tense, there was some tension there). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (more than 36 days have passed since the first dose and the patient has not received the second dose). On 28-Jun-2021, FEELING ABNORMAL (felt as if she was pumped on coffee) and FEELING ABNORMAL (Uncomfortable neck/neck felt like it was very tense, there was some tension there) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (more than 36 days have passed since the first dose and the patient has not received the second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: high (High) Heart rate elevated from 24-Jun-2021 to 28-Jun-2021..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       After 15 minutes patient's neck felt like it was very tense, there was some tension there that caught her attention, it was uncomfortable. This symptom stayed off and on for 4 days. Also her heart rate was elevated for the same amount of time, it felt as if she was pumped on coffee. Patient has not got the second dose yet and wants to know if she should get it. patient's doctor did not give much guidance on it. Patient would like to know what is the maximum dosing interval recommended?
Information has been received from a pharmacist concerning a 76 year old patient (gender and race unspecified). There was no pertinent medical history, concurrent conditions, concomitant medications or drug allergies/drug reactions described. On 09-JAN-2016, the patient received a dose of M-M-R II injection (Lot # J008728 with expiration date of 26-JUL-2015) (strength, dose, frequency and route were not reported) (Expired drug administered). No adverse effects have been reported. Additional information has been requested.
vasovagal syncope, remained in seated position until LOC returned to normal. low BP, low HR remained for several hours
Approx 18-24 hrs after vaccines given at courthouse, presented to ER with purple/blue penis and feet; purplish color noted by ER MD. Transient and resolved in ER. WBC 21,000 - 495, 35 lymph, 13 Mono; Atypical lymphs; ESR - 30; Mom saw peds next day - one more episode since ER. Saw MD 4/3, all labs repeated and normal. Left leg with induration but no swelling/cellulitis around injection sites. No fever.
pediatric dose instead of adult one; pediatric dose instead of adult one; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 20-year-old female patient who received HBV (Engerix B pediatric) (batch number 25N39, expiry date 16th March 2024) for prophylaxis.   On 15th July 2022, the patient received Engerix B pediatric. On 15th July 2022, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK receipt date: 01-Aug-2022 Reporter's comment: The reporter reported that the patient received a pediatric dose of Engerix instead of an adult one. The reporter consented to follow-up. Additional supportive information: The patient received a pediatric dose of Engerix instead of an adult one, which led to underdose and adult use of a child product.
There is a large red oval shaped circle around the injection site.  It is tender, raised, and itchy.
This spontaneous case was reported by a patient and describes the occurrence of SUSPECTED COVID-19 (the patient got Covid again) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for COVID-19 prophylaxis. The patient's past medical history included COVID-19 (Before vaccination with losing taste sucked the first time with mild cough). On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and first dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (unknown route) 1 dosage form. In July 2022, the patient experienced SUSPECTED COVID-19 (the patient got Covid again). At the time of the report, SUSPECTED COVID-19 (the patient got Covid again) outcome was unknown. No concomitant medication was reported. No treatment medication was reported. The patient got Covid again with flu, bad cough, pounding headache, chills, and fatigue considered as symptoms of Suspected COVID-19. The causality of the event Suspected COVID-19 was reported as possible with Janssen COVID-19 vaccine. Company comment: This spontaneous case concerns a patient of unspecified age and gender with underlying medical history of COVID-19 who experienced the unexpected non-serious adverse event of special interest suspected COVID-19 (described as the patient got Covid again) which occurred at an unknown interval after receiving the second dose of mRNA1273. It should be noted that the patient received a dose of different COVID-19 Vaccine (Janssen COVID-19 vaccine) at an unspecified date prior to the latest dose of mRNA1273 (interchange of vaccine products). It was reported that the patient got Covid again with flu, bad cough, pounding headache, chills, and fatigue considered as symptoms of Suspected COVID-19. Further details regarding the clinical course, additional diagnostic or imaging test done, concomitant medications and treatment were not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Sender's Comments: This spontaneous case concerns a patient of unspecified age and gender with underlying medical history of COVID-19 who experienced the unexpected non-serious adverse event of special interest suspected COVID-19 (described as the patient got Covid again) which occurred at an unknown interval after receiving the second dose of mRNA1273. It should be noted that the patient received a dose of different COVID-19 Vaccine (Janssen COVID-19 vaccine) at an unspecified date prior to the latest dose of mRNA1273 (interchange of vaccine products). It was reported that the patient got Covid again with flu, bad cough, pounding headache, chills, and fatigue considered as symptoms of Suspected COVID-19. Further details regarding the clinical course, additional diagnostic or imaging test done, concomitant medications and treatment were not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
At 3:40 PM Interpreter alerted co-lead PHN and Lead PHN to attend to a family of 4 (2 adults and 2 children) in the entry vestibule. Client had just completed observation for his Pfizer COVID-19 second dose lot# FK5127. Client?s mother stated in another language to co-lead PHN, ?my son said he was starting to experience pressure in his chest as we were halfway down the main stairwell. We decided to come back upstairs and notify staff.? At 3:42 PM co-lead PHN and lead PHN instructed client take his mask off and take full breaths. Client was A&Ox4 and did not appear in respiratory distress so co-lead PHN and lead PHN assisted as standby assist for client as he walked back towards the observation room. Co-Lead PHN instructed client to sit down in chair, relax, and to take deep breaths. Client was observed to be A&Ox4, bilateral chest movement equal, with no indications of respiratory distress. Client was unable to accurately express his chest symptoms, client?s mother kept asking what his symptoms were according to the 1-10 rating scale. Client kept stating, ?I don?t know, like a 3 out of 10.? Co-lead PHN asked client if he was concerned about what he was feeling and/or if he felt nervous. Client stated, ?No.? At 3:49 co-lead PHN gave client a bottle of water, client drank water with no issues. Client then stated, ?the pressure in my chest is starting to travel down to my stomach.? Co-lead PHN asked client if the symptoms were feeling worse or better to which client stated, ?it feels about the same, maybe a little better.? Mother disclosed client had ?soup for lunch? with no issues and that her son is very shy and timid about talking to adults. Mother expressed concern about client?s symptoms post vaccination and stated, ?I know how important it is to notify staff of adverse symptoms.? Vitals were then taken at 3:55 PM: manual BP RA: 110/98, HR: 83, SpO2: 99%. Electronic BP RA taken at 3:57 PM: 115/74. Client then stated, ?I feel better now.? Co-lead PHN then educated the client?s mom on adverse reactions and when to go to urgent care, call 911 or go to the emergency room. Co-lead PHN recommended for client to enroll in V-SAFE and to follow-up with the child?s PCP. Client?s mother verbalized understanding. At 4:02 lead PHN escorted client and family downstairs towards the exit of the facility. Client ambulated with steady gait.
Light headed, Nauseous, first day.   diarrhea   Every day since shot   Fatigue all 4 days post vaccine
Patient felt shaky, hot and racing heart with a dry mouth.   Symptoms subsided with in 15 minutes and she felt much better.  Did advise her to follow up with her physician and if signs and symptoms develop or worsen she should seek immediate medical attention.
Immediately following vaccine, left leg felt numb and painful. 2 days later developed right leg pain. Developed eye pain and headache. Fatigue. On 8/23/13 developed Bells Palsy.
I took the 2nd booster at 3:30 pm 5/20th; was fine with soreness setting in at the injection site around 8 pm. I put ice one it before bed and took a Tylenol. At 4:30 am I woke up feeling nauseous. I went to the kitchen to get a piece of ginger candy for it. Leaving the kitchen (maybe 30 seconds later) I started to get light headed. On the way back to my bed the next thing I knew my head hit an end table in my foyer (only 10 steps out of the kitchen) letting me know that I had blacked out! I never hit the floor because I grabbed a chair, took a couple of deep breaths and got back to my bed. I was afraid to go to sleep with after hitting my head so I took the ginger candy why settle my stomach within 5 min. I waiting another 10 min before slowly going back to the kitchen to get ice to put on the right side of my forehead (above my eye) and right side of my face (that was bruised). No bleeding so I just kept icing it every 15 min for 2 hrs. Since I live alone, I texted 2 friends to make them aware. I fell asleep after 2 hrs; woke after 1 hr; iced some more and slept for 1 more hr.  3 hrs later a friend came and took me to the Emergency to get a cat scan; which thankfully came back clean but the doctor said I probably have a minor concussion.
Right arm pain, swelling, went to  ER, went to OR, went to neurology, vascular surgeon, got nerve block. On oxyocodone.
Pt. came into clinic with rash on arm and around injection site. FOC states rash onset was with slight fever and rash also on abdomen.
Severe local erythema, swelling, stiffness with fever up to 102 degrees F.
Beginning at 6:00 AM the following day: lethargy, joint pain/soreness, body aches, chills, fever (highest was 101.4), nausea/vomiting, and headache. Symptoms lasted for 9 hours.
left deltoid pain, mild increase in temperature that was intermittent after patient received vaccine and persistent from 9/21-9/22, causing her to seek appointment at PCP office.
upon administration patient felt itchy no rash/hives/ or other obvious signs.  Gave 25mg of diphenhydramine observed for additional 20 minutes.  at the end of obseravation still no rash/hives or obvious signs. patient stated she felt ok.  called her later that evening for a check in she stated she felt fine
I had shortness of breath on or about July 5th and no appetite.  We called 911.  EMTs gave me oxygen when they arrived.  When we got to the hospital my oxygen continued.  I was admitted to the hospital and stayed about a week.  I was diagnosed with bronchitis and pneumonia.  When  I was released they sent home a breathing treatment machine.
Urticaria without systemic symptoms occurring 3 days after the vaccination. With intense pruritis initially. Begining with the shoulder then to trunk, groin, extremities, axilla, face. Tender lymphadynopathy of left axilla at 1 week. Urticaria progressively lessening and relief with oral antihistamine. However, continuing into 3rd week presently.
3RD DOSE COVID VACCINE GIVEN 10/4/21, PFIZER, #FE3590;  pt had a positive COVID test on 10/1/22 at home; family requested a welfare check; police to pt's house where he was found unresponsive; deceased;
Left pinky toe itchy and swollen/inflamed, sometimes hurts. It's been only a week so far, just started applying Cortizone.
COVID 19 Treatment; COVID 19 Treatment; Modern vaccine number=4/Pfizer BioNTech, vaccine number=3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2 (BNT162B2), on 02Oct2021 as dose 3 (booster), single (Lot number: FF2587) at the age of 32 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 21Sep2022 as dose 4 (booster), single (Lot number: AS7147B), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "ADHD" (unspecified if ongoing), notes: other medical history: ADHD; "scoliosis" (unspecified if ongoing), notes: other medical history: scoliosis; "known allergies: Shrimp" (unspecified if ongoing), notes: known allergies: Shrimp. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 21Sep2022, outcome "unknown", described as "Modern vaccine number=4/Pfizer BioNTech, vaccine number=3"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Barely tested positive for COVID-19, started PAXLOVID; (unspecified date) Positive, notes: two days after that, VERY strong positive, and slight return of symptoms; (30Jul2023) Positive, notes: at end of treatment still only had very faint positive,; (01Aug2023) Negative, notes: two days later, negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was reported that the patient has received other medication in 2 weeks and was barely tested positive for COVID-19, started PAXLOVID, at end of treatment still only had very faint positive, two days later negative, two days after that, VERY strong positive, and slight return of symptoms.
Low grade fever on Tuesday evening. TYLENOL given. Slept well over night. Wednesday, fever of 100-101 @ noon. Then up to 104.5. TYLENOL given. Fussy, lethargic.  Thursday, fever came down to 103.0 @ noon. Diarrhea x 5 on Friday, but content and perky. Sm red raised lump on (R) upper thigh.
onset of fever, respiratory symptoms, congestion, runny nose then acute gout (never had gout before) gout started 01-27-2010. symptoms continued through 02/09/2010
FLUMISt and MENACTRA administered 10/31/08. Sore arm 11/1, mild body aches 11/2, in bed with  severe body aches 11/3 -11/6. No fever/UBI/GI Sx normal exam 11/7/08
Child received influenza vaccine at approximately 1:30 p.m. on 11/14/08, about 1/2 hour after administration, father called to report that child was "out of it", looked pale, doesn't want to do anything.  Nurse advised parent to lay child down, elevate legs/feet and use cold cloth or ice pack.  Father advised by nurse that if he continues to have problems to take the child to the ER, since child does not have a primary physician.  11/17/08 Follow-up call to parents by RN, mom reports child was taken to ER, his temperature was 102-103, he very pale and a "swollen throat", Mom states child started to "come around" after ER gave medication (mother unaware what medication was given), and child was sent home.  Child today is having no problems. Information given to mom regarding VAERS and vaccine compensation program.  Advised mother this would be reported by this office to VAERS.
headache; arm soreness near the site of injection; This is a spontaneous report from a contactable consumer, the patient. This 5-decade-old female patient (reported as in her late 40's) received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: UNKNOWN), first dose, unspecified route of administration on an unspecified date in Jan2021 as a single dose for COVID-19 vaccination. The patient's medical history included psoriasis from an unknown date an unknown if ongoing. The patient's concomitant medications were not reported. On an unspecified date in Jan2021, the patient experienced a headache immediately following the first injection of the vaccine. Several hours later, the patient experienced arm soreness near the site of injection in the arm that received the injection. The clinical outcome of the headache and arm soreness near the site of injection was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient presented with one week of back, right leg and right groin pain.  Right lower extremity swelling and was diagnosed with deep vein thrombosis from right popliteal vein into IVC involving a renal vein.  He is on anticoagulation currently and going for catheter-directed thrombolysis today.  Patient has been in hospital two days and hospitalization is ongoing at the time of this report.
Patient developed discomfort at site of immunization and pain in upper shoulder. Noticed a lump above collar bone and went to MD office to have it checked.
Patient had lightheadedness, dizziness and started to look pale.  EMS services was contact at 4:15pm. Patient was put into supine position and elevated the patients legs to help increase blood flow. Patient was instructed to continue to count and stay talking until EMS arrived.  Patient started to regain color and was alert to person, place and time. EMS arrived at 4:24pm but patients parents denied EMS service because patient was feeling better.